MedTrace Logo

Effect of Testofen on Erectile Function in an Adult Male Population

NCT05232279 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-07-24

No results posted yet for this study

Summary

This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.

Conditions

Interventions

DRUG

Testofen 300mg

Testofen in capsule form - To be taken as a 300mg dosage (2 capsules) once daily for 12 weeks.

DRUG

Testofen 600mg

Testofen in capsule form - To be taken as a 600mg dosage (2 capsules) once daily for 12 weeks.

DRUG

Placebo comparator

The placebo will consist of maltodextrin and will appear identical to the Testofen capsules. The placebo will be administered as per the active treatment - 2 capsules once daily for 12 weeks.

Sponsors & Collaborators

  • RDC Clinical Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Amanda Rao, PhD · RDC Clinical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-19
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05232279 on ClinicalTrials.gov